Pharmafile Logo

WG Consulting

The WG Group provides bespoke Market Access consultancy services for all healthcare stakeholders. These include the pharmaceutical, medical devices and diagnostics industries, the independent sector, European state healthcare providers and academia. Its unique blend of experience and expertise enables the WG Group to provide innovative solutions effectively tailored to clients’ needs. The WG Group is part of the Grey Healthcare Group, one of the world’s largest healthcare communications agency networks and part of the WPP Group of companies which gives our clients access to an unparalleled breadth of global expertise.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

WG House, 2 Cressex Road, High Wycombe, Buckinghamshire, HP12 4TY, United Kingdom
+44 (0)1494 470760

 Latest Content from PMHub 

How can pharma align its brand strategy with the NHS Reset?

Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...

A Lucid Group Thirsty Thursday: change management and self-efficacy

Last week, Lucid Group were lucky enough to have Richard Nugent, Founder and Managing Director of TwentyOne Leadership, present a session on change management and self-efficacy. Richard often works with...

Lucid Group expand its UK office footprint in Macclesfield

Lucid Group is increasing its share of office space on the popular Tytherington Business Village, after a sustained period of growth, which has seen it outperform a buoyant marketplace and taken...

How does nature influence wellbeing and refocus the mind?

Time is the 21st century's most precious commodity – we all live in a world where rushing around seems more normal than having a relaxing coffee break

Article

White Papers and Resources | October 30, 2020 | Inizio

How will COVID-19 affect uptake of vaccinations against other diseases?

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Podcast

White Papers and Resources | October 30, 2020 | Inizio

Living With Chronic Illness (Series one)

How to make an impact at a virtual congress

As hard as congress organisers try, replicating the congress experience on a virtual platform is difficult. Rather than trying to replicate the in-person congress experience, the industry has a real...

Webcast

White Papers and Resources | October 30, 2020 | Inizio

China: How pharma can maximize success in this rapidly changing emerging market